BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 6410531)

  • 1. Blood viscosity and haemostasis in the nephrotic syndrome.
    McGinley E; Lowe GD; Boulton-Jones M; Forbes CD; Prentice CR
    Thromb Haemost; 1983 Jun; 49(3):155-7. PubMed ID: 6410531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal haemostasis and blood viscosity in malignant hypertension.
    Isles C; Lowe GD; Rankin BM; Forbes CD; Lucie N; Lever AF; Kennedy AC
    Thromb Haemost; 1984 Dec; 52(3):253-5. PubMed ID: 6241751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma viscosity as a cardiovascular risk marker in patients with proteinuria.
    Ercan M; Konukoglu D; Onen S
    Clin Hemorheol Microcirc; 2003; 29(2):111-6. PubMed ID: 14610306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma viscosity in nephrotic Nigerians.
    Oviasu E; Famodu AA; Ojeh EA
    Clin Hemorheol Microcirc; 1998 Oct; 19(2):163-7. PubMed ID: 9849930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High levels of tissue factor pathway inhibitor in patients with nephrotic proteinuria.
    Ariëns RA; Moia M; Rivolta E; Ponticelli C; Mannucci PM
    Thromb Haemost; 1999 Sep; 82(3):1020-3. PubMed ID: 10494757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions.
    Zwaginga JJ; Koomans HA; Sixma JJ; Rabelink TJ
    J Clin Invest; 1994 Jan; 93(1):204-11. PubMed ID: 8282789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive study of haemostasis in nephrotic syndrome.
    Panicucci F; Sagripanti A; Vispi M; Pinori E; Lecchini L; Barsotti G; Giovannetti S
    Nephron; 1983; 33(1):9-13. PubMed ID: 6403881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma fibronectin and factor XIII in nephrotic syndrome.
    Rus HG; Cucuianu M; Manasia M; Spînu C; Cristea A; Nanulescu M
    Med Interne; 1987; 25(2):105-11. PubMed ID: 3112925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased aggregation with normal surface charge and deformability of red blood cells in children with nephrotic syndrome.
    Böhler T; Linderkamp O; Leo A; Wingen AM; Schärer K
    Clin Nephrol; 1992 Sep; 38(3):119-24. PubMed ID: 1395161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in several blood coagulation parameters in the nephrotic syndrome].
    Gasparotto ML; Bertoli M; Bertaglia E; Vertolli U; Varchetta V; Favaro P; Rebeschini M; Di Lavoro D; Romagnoli GF
    Minerva Nefrol; 1981; 28(1):15-9. PubMed ID: 6793942
    [No Abstract]   [Full Text] [Related]  

  • 12. [Mechanism of renal vein thrombosis in patients with nephrotic syndrome: a prospective study].
    Cheng H
    Zhonghua Yi Xue Za Zhi; 1992 Jul; 72(7):416-9, 447. PubMed ID: 1330232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of selected parameters of hemostasis in patients with nephrotic syndrome].
    Rowiński M; Rydzewski A; Małyszko JS; Małyszko J; Myśliwiec M
    Przegl Lek; 1994; 51(2):77-81. PubMed ID: 8058973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevation of blood viscosity, aggregation of red cells, haematocrit values and fibrinogen levels with cigarette smokers.
    Dintenfass L
    Med J Aust; 1975 May; 1(20):617-20. PubMed ID: 1143159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behaviour of fibrinolysis in the nephrotic syndrome.
    Cucuianu M; Manasia M; Spînu C; Mărcuşu C; Roman S; Comănescu A
    Med Interne; 1988; 26(2):109-14. PubMed ID: 3133746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma levels and urinary excretion of fibrinolytic and protease inhibitory proteins in nephrotic syndrome.
    Vaziri ND; Gonzales EC; Shayestehfar B; Barton CH
    J Lab Clin Med; 1994 Jul; 124(1):118-24. PubMed ID: 7518491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet aggregation and beta-thromboglobulin levels in nephrotic patients with and without thrombosis.
    Kuhlmann U; Steurer J; Rhyner K; von Felten A; Briner J; Siegenthaler W
    Clin Nephrol; 1981 May; 15(5):229-35. PubMed ID: 6166421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor XII and other hemostatic protein abnormalities in nephrotic syndrome patients.
    Thompson AR
    Thromb Haemost; 1982 Aug; 48(1):27-32. PubMed ID: 6813992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of platelets in patients with chronic proliferative glomerulonephritis and the nephrotic syndrome.
    Tomura S; Ida T; Kuriyama R; Chida Y; Takeuchi J; Motomiya T; Yamazaki H
    Clin Nephrol; 1982 Jan; 17(1):24-30. PubMed ID: 6459902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.
    Erem C; Kocak M; Hacihasanoglu A; Yilmaz M; Saglam F; Ersoz HO
    Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.